Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

Bullboard (CSE:AGN)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by TheBearInTheWoodson Mar 28, 2023 11:18pm

RE:A Message To Board Director - Dr. Mark Williams, PhD, MBA

You are still in this dog lmao, ARCH was just given the market cap or AGN in a gov grant for a NEW mechanism of action. 
65
Discussion
Post by Whalewatcher1on Mar 28, 2023 7:58pm

Trading starting March 29th will be interesting

Shouldnt the stock be trading well below $0.25? if current shareholders can buy the rights offering for $0.25 an get a warrant, won't every current investor be selling at below $0.25?  will ...more  
212
Discussion
Comment by C10H12N2on Mar 28, 2023 7:33pm

RE:Interview with CEO on Upcoming Clinical Trial

Man these bots post up some dumb down stuff. The video attached is from 2 months ago. Is it that hard to see they have NO MONEY to run a Chronic Cough trial or any trial? What money they'll ...more  
63
Discussion
Post by SkywalkerofLukeon Mar 28, 2023 3:58pm

Interview with CEO on Upcoming Clinical Trial

A US survey found that 5% of people (approximately 12.2 million adults) reported experiencing chronic cough in the previous 12 months. The chronic cough market is expected to reach $11.38B by 2029.  ...more  
109
Discussion
Post by StockHawk1on Mar 27, 2023 6:39pm

AGN DMT-Stroke research video

There are currently very few treatment options for stroke survivors other than blood thinners or surgical intervention. Given the neuro-generative effects of DMT, it could have brain-healing ...more  
103
Post by C10H12N2on Mar 27, 2023 2:58am

A Message To Board Director - Dr. Mark Williams, PhD, MBA

t's ok if you let your baby out of it's Play Pen and let it run free. Nobody is going to criticize you for having sidestepped the type of mathematical and methodical missteps that are ...more  
294
Discussion
Post by StockHawk1on Mar 24, 2023 7:22pm

AGN's DMT studies

The phara-development company Algernon Pharmaceuticals (AGN.c AGNPF) is helping to pave the way in psychdelic medicine by studying if DMT can help patients with brain injuries. The company is doing ...more  
146
Post by C10H12N2on Mar 24, 2023 2:43am

4 BILLION SHARES In 4+ Years With No End In Sight

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171525796
175
Post by StockHawk1on Mar 23, 2023 7:38pm

CEO on DMT study (1st dose completed)

In this interview Algernon Pharmaceuticals (AGN.c AGNPF) CEO shares the news that AGN has completed the first dosing in its Phase 1 clinical study of DMT.  The video goes in-depth into AGN's ...more  
173
Comment by waves1on Mar 23, 2023 4:14pm

RE:Interview with CEO

It's notable that AGN is able to accelerate to a Phase 2 clinical trial of DMT for TBI by using the data from its Phase 1 Study of DMT for Stroke.
65
Discussion
Comment by Whalewatcher1on Mar 22, 2023 10:12am

RE:3 Ring Circus Act

Ya, surprised its not trading at $0.25
68
Discussion
Post by C10H12N2on Mar 22, 2023 8:38am

3 Ring Circus Act

AGN - AGN Neuro - AGN.RT  Why buy/hold 40 cent shares when you can now buy/hold 25 cent shares?
142
Discussion
Comment by C10H12N2on Mar 21, 2023 11:02pm

RE:Is this the beginning of the end?

If nothing else...the CEO has a proven track record of Bankrupt companies.
51
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities